Gabriel Di Blasi, Managing Partner at Di Blasi, Parente & Associados in Brazil and researcher Alexandre de Calais Filho highlight sustainable innovation in Brazil...
As research and development efforts move forward in relation to Chimeric antigen receptor CAR-T cells, it is interesting to understand the main patentability issues of...
Chimeric antigen receptor (CAR) T-cell therapy is a personalised cancer treatment that is gaining greater visibility and enthusiasm as research advances and success in...
In recent years, the Patent Board of the Brazilian Patent and Trademark Office (National Institute of Industrial Property “INPI”) has implemented a series of...
Divisional applications are a useful tool when considering patent strategy in Brazil. This blog touches on the main points of the prosecution of divisional...
Understanding the ongoing discussion and the good to come
Much – and even some contradictory information – has been published about the judicial action at...
FICPI is the only international NGO whose membership consists exclusively of IP attorneys in private practice. As a result, the FICPI community is driven by a shared interest to promote solutions and advocacy for private IP practitioners.